Robert A. Wise

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

Nicholas R. Anthonisen, M.A. Skeans, Robert A. Wise et al. · Annals of Internal Medicine · 2005 · 1.2K citations

Public Health, Preventive Medicine, Outcomes Research +9

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1.1K citations

Medicine, Pharmacology, Pharmacotherapy +11

Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma

Michael J. McGeachie, Katherine P. Yates, Xiaobo Zhou et al. · New England Journal of Medicine · 2016 · 602 citations · Full text

Medicine, Child Health, Pediatrics +13